血清肌钙蛋白水平对急性心梗病人护理评估的指导分析

目的分析血清肌钙蛋白I代谢特点和急性心梗病人(AMT)心肌损害程度之间关系,探讨以生物分子学数据作为急性心梗病人(AMT)护理评估依据。方法将64例患者按入院时间先后顺序随机分到常规组(34例)和观察组(34例)。采集病人入院后各个时段的静脉血,进行生化分析,评估病人心肌受损情况,指导急性心梗病人护理计划的制定。结果应用生物分子学评估优势大于临床症状学评估,变异系数小。结论血清肌钙蛋白水平作为指导制定急性心梗病人护理计划有可行性。其准确性高、科学性强、临床便于操作。肌钙蛋白I(cTnI)可以作为急性心梗病人护理评估的分子标记物之一。

Objective The analysis blood serum myo-calcium protein Ⅰ metabolism characteristic and the acute heart stem patient （AMT） between the cardiac muscle extent of damage relates, discusses takes the acute heart stem patient by the biological member study data （AMT） to nurse the appraisal basis. Method 64 example patients according to hospital time successively order along with fuselage to conventional group （34 examples） and observation group （34 examples）. After gathering the patient is hospitalized, each time interval venous blood, carries on the biochemistry analysis, appraises the patient cardiac muscle to suffer injury the situation, the instruction acute heart stem patient care plan formulation. Result The.application biology member study appraisal superiority is bigger than the clinical symptomatology to appraise, the coefficient of variation is small. Conclusion The blood serum myo-calcium protein level has the feasibility as the instruction formulation acute heart stem patient care plan. Its accuracy is high, the scientific nature strong, clinical is advantageous for the operation. Myo-calcium protein Ⅰ（cTnⅠ） may take one of acute heart stem patient care appraisal molecular tracers.